In November of 2008, Aduramed successfully filed a US Patent on its containerized sterilization process, protocol, and autoclave standard. The name for the process is MedClean. Events have progressed rapidly over the last several months. Effectively, the Aduramed patent application has now become a working MedClean business opportunity. The company was able to do this because sterilization is not just about the end product, but also about the safe handling of all hazardous medical wastes from start to finish. In short, it is about safety for all hospital personnel involved with the disposal process.
Timeline of Company Updates: Since November, Aduramed has announced several changes that directly affect its business plan. In December 2008, they revealed the retirement of Damien Tanaka, the company’s founder. On January 2nd, they announced a name change to MedClean that included a switch in their stock symbol on the OTC Bulletin Board to “MCLN”. On February 12th, 2009, the CEO released a letter of intent to its shareholders that outlined a new business strategy to expand into a $2 billion market using the new patented technology. On February 18th, 2009, MedClean announced its first $1 million finalized contract under that new plan.
About The MedClean Process
The patent application is titled “Containerized Medical Waste Treatment System and Related Method”. The extensively researched, tested, and third-party validated protocol is the foundation for proprietary software and hardware products. These enable the new system to meet or exceed all regulatory standards in all 50 states. The company says that this innovative approach stems from the most comprehensive study conducted in the industry. Aduramed authored this study itself – gathering expert and customer testimony within the target market.
The series of containerized systems makes it easier and more cost effective for healthcare professionals to implement onsite solutions to handle regulated medical wastes. It also mitigates risks and advances environmental objectives. The shredding and autoclave sterilization subsystems are part of the ‘Green’ theme. A balanced approach to differential heating and vacuum cycles optimizes the sanitization efficacy of the procedure. The end product is a reduced volume of inert material that is completely safe for use as landfill.
The use of various types of autoclave sterilization for medical waste applications is rapidly gaining momentum around the globe. This new sterilization solution has recently proven to be extraordinarily viable and may very well offer the best approach. MedClean’s patent includes a standard for the waste sterilization process. It also covers a practical containerized method to control the waste before it reaches the autoclave.
MedClean’s goal is to ensure safety for everyone. The adoption of these assimilated turnkey technologies and protocol techniques is expected to accelerate as more people become aware of the advantages. The company will hold an exhibition at the ASHES 24th Annual Conference and Healthcare Marketplace on September 21st and 22nd 2009 at the Grand Sierra Resort in Reno, Nevada to promote its new systems.
As a business professional, you understand the importance of having access to the latest information when you are making a decision. To find up to date information on how to pick the right sterilization equipment for your facility, see our free report.